SensID Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

SensID General Information

Description

Manufacturer of biotechnology reference materials and quality controls designed for molecular diagnostics with a focus on oncology and precision medicine. The company's platform specializes in research and development, instrument validation, external control, accreditation preparation, proficiency testing, and conformity assessment in full compliance with the relevant quality, enabling clients to improve patient outcomes and reduce costs.

Contact Information

Website
www.sens-id.com
Formerly Known As
SensID UG (haftungsbeschränkt)
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Schillingallee 68
  • 18057 Rostock
  • Germany
+49 0381
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Devices and Supplies
Biotechnology
Parent Company
Corporate Office
  • Schillingallee 68
  • 18057 Rostock
  • Germany
+49 0381

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SensID Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SensID‘s full profile, request access.

Request a free trial

SensID Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of biotechnology reference materials and quality controls designed for molecular diagnostics with a focus o
Other Pharmaceuticals and Biotechnology
Rostock, Germany
15 As of 2024

Cambridge, United Kingdom
 

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SensID Competitors (2)

One of SensID’s 2 competitors is Horizon Discovery, a Formerly VC-backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Horizon Discovery Formerly VC-backed Cambridge, United Kingdom
Horizon Pharma (primary care unit) Failed Transaction (M&A)
You’re viewing 2 of 2 competitors. Get the full list »

SensID Patents

SensID Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4720329-A1 Reference material comprising nucleic acids having a fragmentation and nucleosome profile and diagnostic method Pending 26-May-2023
US-20260347927-A1 Reference material comprising nucleic acids having a fragmentation and nucleosome profile and diagnostic method Pending 26-May-2023
WO-2024246014-A1 Reference material comprising nucleic acids having a fragmentation and nucleosome profile and diagnostic method Inactive 26-May-2023
EP-4467659-A1 Reference material comprising nucleic acids with a fragmentation and nucleosome profile and diagnosis Inactive 26-May-2023
EP-4123033-A1 Blood matrix as reference material for in vitro diagnosis Inactive 21-Jul-2021 C12Q1/6806
To view SensID’s complete patent history, request access »

SensID Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SensID Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SensID‘s full profile, request access.

Request a free trial

SensID FAQs

  • When was SensID founded?

    SensID was founded in 2015.

  • Where is SensID headquartered?

    SensID is headquartered in Rostock, Germany.

  • What is the size of SensID?

    SensID has 15 total employees.

  • What industry is SensID in?

    SensID’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is SensID a private or public company?

    SensID is a Private company.

  • What is SensID’s current revenue?

    The current revenue for SensID is .

  • Who are SensID’s investors?

    GENIUS Venture Capital and OstseeSparkasse Rostock have invested in SensID.

  • Who are SensID’s competitors?

    Horizon Discovery and Horizon Pharma (primary care unit) are competitors of SensID.

  • When was SensID acquired?

    SensID was acquired on 06-Nov-2024.

  • Who acquired SensID?

    SensID was acquired by Microbiologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process